In animals, SSADH has been produced in knockout mice; clinical signs are progressive ataxia, failure to thrive, seizure and death at a young age [53,54], and thus they are utilized as a model for the severe and poor survival phenotype in humans. This evidence concerns the gene ALDH5A1 and cerebellar ataxia.